TLSIW TriSalus Life Sciences, Inc. - Warrant
$0,56
Cena · Sie 14, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$0–$2
7% of range
Ocena Analityków
—
Cena Docelowa
—
P/E (TTM)
-0.4
ROE
147.2%
Marża Zysku Netto
-86.9%
TLSIW Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.56
Kapitalizacja Rynkowa
$34M
P/E (TTM)
-0.4
EPS (TTM)
$-1.84
Przychody (TTM)
$45M
Stopa dywidendy
—
ROE
147.2%
D/E Dług/Kapitał
-1.0
Zakres 52 tyg.
$0 – $2
TLSIW Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$45M
2022-12-31
→
2025-12-31
EPS
$-1.84
2022-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-19M
2023-12-31
→
2025-12-31
Marże
-86.9%
2023-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TLSIW
Mediana porównawcza
P/E (TTM)
-0.4
—
P/S (TTM)
0.8
—
P/B
-1.0
—
EV / EBITDA
-1.7
—
Price / FCF (Cena / FCF)
-1.8
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TLSIW
Mediana porównawcza
Gross Margin (Marża brutto)
84.6%
—
Operating Margin (Marża Operacyjna)
-59.7%
—
Net Profit Margin (Marża Zysku Netto)
-86.9%
—
ROA
-132.3%
—
ROE
147.2%
—
ROIC
3306.8%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TLSIW
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
-1.0
—
Current Ratio (Wskaźnik bieżący)
2.8
—
Quick Ratio (Wskaźnik Szybkości)
2.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TLSIW
Mediana porównawcza
Revenue YoY (Przychody R/R)
53.4%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
53.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TLSIW
Mediana porównawcza
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $45M | $29M | $19M | $12M | |
| Cost of Revenue | $7M | $4M | $3M | $2M | |
| Gross Profit | $38M | $25M | $16M | $10M | |
| R&D Expense | $15M | $18M | $30M | $21M | |
| SG&A Expense | $21M | $18M | $24M | $12M | |
| Operating Income | $-27M | $-36M | $-54M | $-36M | |
| Interest Expense | · | · | $16.0K | $1.0K | |
| Interest Income | $555.0K | $404.0K | $431.0K | $180.0K | |
| Other Non-op | $-456.0K | $-312.0K | $-378.0K | $-420.0K | |
| Pretax Income | $-39M | $-30M | $-59M | $-47M | |
| Income Tax | $7.0K | $6.0K | $9.0K | $9.0K | |
| Net Income | $-39M | $-30M | $-59M | $-47M | |
| EPS (Basic) | $-1.84 | $-1.31 | $-6.77 | $-161.55 | |
| EPS (Diluted) | $-1.84 | $-1.31 | $-6.77 | $-161.55 | |
| Shares (Basic) | 37,897,785 | 25,331,753 | 9,395,748 | 309,609 | |
| Shares (Diluted) | 37,897,785 | 25,331,753 | 9,395,748 | 309,609 | |
| EBITDA | $-27M | $-36M | $-54M | $-3M |
Bilans 22
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $9M | $12M | $9M | |
| Receivables | $7M | $5M | $4M | $2M | |
| Inventory | $3M | $4M | $3M | $1M | |
| Prepaid Expense | $2M | $3M | $3M | $5M | |
| Current Assets | $32M | $21M | $21M | $17M | |
| PP&E (Net) | · | · | $2M | $2M | |
| Intangibles | · | · | $0 | $802.0K | |
| Other Non-current Assets | $418.0K | $423.0K | $466.0K | $367.0K | |
| Total Assets | $35M | $24M | $25M | $22M | |
| Accounts Payable | · | · | · | $1M | |
| Accrued Liabilities | $8M | $7M | $11M | $6M | |
| Short-term Debt | · | · | · | $944.0K | |
| Current Liabilities | $11M | $10M | $15M | $32M | |
| Capital Leases | $1M | $1M | $1M | · | |
| Total Liabilities | $69M | $50M | $52M | $34M | |
| Total Debt | $33M | $22M | · | · | |
| Common Stock | $4.0K | $3.0K | $2.0K | $0 | |
| Paid-in Capital | $297M | $254M | $222M | $10M | |
| Retained Earnings | $-331M | $-280M | $-250M | $-186M | |
| Stockholders' Equity | $-34M | $-26M | $-27M | $-177M | |
| Liabilities + Equity | $35M | $24M | $25M | $22M | |
| Shares Outstanding | 49,997,836 | 31,279,264 | 26,413,213 | 347,926 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $626.0K | $744.0K | $684.0K | $398.0K | |
| Stock-based Comp | $9M | $5M | $1M | $368.0K | |
| Amort. of Intangibles | · | · | $18.0K | $122.0K | |
| Operating Cash Flow | $-18M | $-41M | $-51M | $-32M | |
| CapEx | $918.0K | $345.0K | $588.0K | $655.0K | |
| Investing Cash Flow | $-838.0K | $-345.0K | $-2M | $-2M | |
| Stock Issued | $22M | $15M | $0 | · | |
| Stock Repurchased | · | · | · | $232M | |
| Net Stock Activity | $22M | $16M | · | $-232M | |
| Financing Cash Flow | $31M | $38M | $55M | $13M | |
| Net Change in Cash | $12M | $-3M | $2M | $-21M | |
| Taxes Paid | $16.0K | $18.0K | $14.0K | $9.0K | |
| Free Cash Flow | $-19M | $-41M | $-51M | · | |
| Levered FCF | · | · | $-51M | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 84.6% | 86.1% | 85.9% | · | |
| Operating Margin | -59.7% | -122.9% | -292.5% | · | |
| Net Margin | -86.9% | -102.1% | -318.9% | · | |
| Pretax Margin | -86.9% | -102.1% | -318.9% | · | |
| EBITDA Margin | -59.7% | -122.9% | -292.5% | · | |
| ROA | -132.3% | -123.7% | -247.4% | 4.1% | |
| ROE | 147.2% | 129.7% | 669.1% | -6.6% | |
| ROIC | 3306.8% | 949.4% | 208.8% | 18.8% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.0 | 1.4 | 0.1 | |
| Quick Ratio | 2.3 | 1.3 | 1.0 | 0.1 | |
| Debt / Equity | -1.0 | -0.9 | · | · | |
| LT Debt / Equity | -1.0 | -0.9 | · | · | |
| Interest Coverage | · | · | -3384.4 | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.2 | 0.8 | · | |
| Inventory Turnover | 2.0 | 1.2 | 1.3 | · | |
| Receivables Turnover | 7.8 | 6.8 | 7.2 | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 53.4% | 59.0% | 49.3% | · | |
| Revenue CAGR 3Y | 53.8% | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $45M | $29M | $19M | $12M | |
| Net Income TTM | $-39M | $-30M | $-59M | $-47M | |
| Market Cap | $83M | $34M | $31M | · | |
| Enterprise Value | $96M | $48M | · | · | |
| P/E | -0.9 | -0.8 | -0.2 | -0.0 | |
| P/S | 1.8 | 1.2 | 1.7 | · | |
| P/B | -2.5 | -1.3 | -1.2 | · | |
| P / Cash Flow | -4.6 | -0.8 | -0.6 | · | |
| P / FCF | -4.4 | -0.8 | -0.6 | · | |
| EV / EBITDA | -3.5 | -1.3 | · | · | |
| EV / FCF | -5.1 | -1.2 | · | · | |
| EV / Revenue | 2.1 | 1.6 | · | · | |
| Earnings Yield | -110.8% | -119.1% | -568.9% | -215400.0% |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | $9M | $13M | $12M | $11M | $9M | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $3M | $3M | $4M | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $912.0K | $971.0K | $582.0K | $589.0K | $772.0K | $662.0K | $816.0K | $701.0K | |
| Gross Profit | $10M | $8M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $2M | $2M | $3M | |
| R&D Expense | $3M | $3M | $3M | $5M | $4M | $3M | $3M | $4M | $5M | $6M | $8M | $10M | $7M | $6M | $6M | $5M | |
| SG&A Expense | $5M | $5M | $4M | $7M | $6M | $5M | $5M | $5M | $4M | $5M | $6M | $9M | $5M | $4M | $8M | $3M | |
| Operating Income | $-10M | $-8M | $-3M | $-9M | $-7M | $-7M | $-8M | $-9M | $-8M | $-12M | $-14M | $-19M | $-11M | $-10M | $-27M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $877.0K | $3.0K | · | $4.0K | $4.0K | $5.0K | $1.0K | $0 | |
| Interest Income | $457.0K | $164.0K | $177.0K | $170.0K | $134.0K | $74.0K | $57.0K | $158.0K | $97.0K | $92.0K | $244.0K | $116.0K | $36.0K | $35.0K | $-240.9K | $49.0K | |
| Other Non-op | $90.0K | $-76.0K | $-71.0K | $-94.0K | $-40.0K | $-251.0K | $-102.0K | $-13.0K | $-44.0K | $-153.0K | $-321.0K | $-13.0K | $-25.0K | $-19.0K | $-7M | $-31.0K | |
| Pretax Income | $-9M | $2M | $-10M | $-11M | $-8M | $-10M | $-10M | $-2M | $-4M | $-13M | $-36M | $-1M | $-14M | $-8M | $-44M | $-8M | |
| Income Tax | $4.0K | $4.0K | $0 | $5.0K | $-3.0K | $5.0K | $-1.0K | $-3.0K | $7.0K | $3.0K | $1.0K | $0 | $13.0K | $-5.0K | $-19.2K | $0 | |
| Net Income | $-9M | $2M | $-10M | $-11M | $-8M | $-10M | $-10M | $-2M | $-4M | $-13M | $-36M | $-1M | $-14M | $-8M | $-23M | $-8M | |
| EPS (Basic) | $-0.16 | $0.03 | $-0.22 | $-0.96 | $-0.27 | $-0.39 | $-0.38 | $-0.12 | $-0.21 | $-0.60 | $29.78 | $-0.14 | $-35.84 | $-0.57 | $-79.38 | $-25.95 | |
| EPS (Diluted) | $-0.16 | $0.03 | $-0.22 | $-0.96 | $-0.27 | $-0.39 | $-0.38 | $-0.12 | $-0.21 | $-0.60 | $29.78 | $-0.14 | $-35.84 | $-0.57 | $-79.38 | $-25.95 | |
| Shares (Basic) | 58,296,711 | 51,539,682 | -66,586,597 | 43,057,632 | 32,899,297 | 28,527,453 | -48,396,548 | 26,501,597 | 23,903,659 | 23,323,045 | -20,390,542 | 13,173,422 | 446,287 | 16,166,581 | 9,673 | 311,823 | |
| Shares (Diluted) | 58,296,711 | 52,314,410 | -66,586,597 | 43,057,632 | 32,899,297 | 28,527,453 | -48,396,548 | 26,501,597 | 23,903,659 | 23,323,045 | -20,390,542 | 13,173,422 | 446,287 | 16,166,581 | 9,673 | 311,823 | |
| EBITDA | $-10M | $-8M | · | $-9M | $-7M | $-7M | · | $-9M | $-8M | $-12M | · | $-18M | $-1M | $-843.3K | · | $-432.2K |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $57M | $20M | $23M | $26M | $13M | $9M | $11M | $16M | $4M | $12M | $21M | $104.0K | $136.8K | $9M | $207.6K | |
| Receivables | $6M | $5M | $7M | $5M | $6M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | · | · | $2M | · | |
| Inventory | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | · | · | $1M | · | |
| Prepaid Expense | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $57.5K | $164.1K | $5M | $98.6K | |
| Current Assets | $60M | $68M | $32M | $33M | $38M | $25M | $21M | $24M | $28M | $13M | $21M | $29M | $161.5K | $300.9K | $17M | $306.2K | |
| PP&E (Net) | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $1M | $1M | $0 | $997.0K | · | · | $802.0K | · | |
| Other Non-current Assets | $69.0K | $69.0K | $418.0K | $419.0K | $419.0K | $424.0K | $423.0K | $424.0K | $424.0K | $424.0K | $466.0K | $367.0K | · | · | $367.0K | · | |
| Total Assets | $62M | $71M | $35M | $36M | $41M | $29M | $24M | $27M | $32M | $18M | $25M | $34M | $12M | $21M | $22M | $251M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | · | · | |
| Accrued Liabilities | $7M | $7M | $8M | $7M | $7M | $8M | $7M | $8M | $9M | $11M | $11M | $7M | · | · | $6M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | · | |
| Current Liabilities | $11M | $12M | $11M | $11M | $9M | $12M | $10M | $10M | $12M | $14M | $15M | $9M | $6M | $5M | $32M | $2M | |
| Capital Leases | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $56M | $58M | $69M | $63M | $61M | $63M | $50M | $48M | $57M | $53M | $52M | $25M | $15M | $14M | $34M | $12M | |
| Total Debt | $33M | $33M | · | $33M | $32M | $32M | · | $22M | $21M | · | · | · | $2M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | · | $0 | · | |
| Paid-in Capital | $345M | $342M | $297M | $294M | $279M | $256M | $254M | $249M | $242M | $227M | $222M | $221M | · | · | $10M | · | |
| Retained Earnings | $-338M | $-329M | $-331M | $-321M | $-298M | $-290M | $-280M | $-269M | $-266M | $-262M | $-250M | $-213M | $-15M | $-14M | $-186M | $-12M | |
| Stockholders' Equity | $7M | $13M | $-34M | $-27M | $-19M | $-34M | $-26M | $-20M | $-24M | $-35M | $-27M | $8M | $-15M | $-14M | $-176M | $-12M | |
| Liabilities + Equity | $62M | $71M | $35M | $36M | $41M | $29M | $24M | $27M | $32M | $18M | $25M | $34M | $12M | $21M | $22M | $251M | |
| Shares Outstanding | 61,469,572 | 61,414,355 | 49,997,836 | 49,891,299 | 37,983,259 | 32,272,462 | 31,279,264 | 30,469,664 | 27,159,463 | 26,758,272 | 26,413,213 | 26,316,681 | · | · | 347,926 | · |
Przepływy pieniężne 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $135.0K | $126.0K | $163.0K | $165.0K | $172.0K | $193.0K | $169.0K | $181.0K | $175.0K | $194.0K | $156.0K | $150.0K | $184.0K | $-54.0K | · | |
| Stock-based Comp | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $260.0K | $68.0K | $74.0K | $117.0K | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | $0 | $13.0K | · | · | $0 | $22.0K | · | · | |
| Operating Cash Flow | $-10M | $-6M | $-2M | $-4M | $-7M | $-4M | $-6M | $-11M | $-13M | $-11M | $-9M | $-40M | $-19M | $-11M | $-8M | $-23M | |
| CapEx | $82.0K | $141.0K | $41.0K | $216.0K | $-93.0K | $754.0K | $50.0K | $169.0K | $60.0K | $66.0K | $372.0K | $178.0K | $31.0K | $7.0K | $204.0K | · | |
| Investing Cash Flow | $-82.0K | $-141.0K | $-41.0K | $-176.0K | $93.0K | $-714.0K | $-50.0K | $-169.0K | $-60.0K | $-66.0K | $-372.0K | $-9M | $130.4K | $-74.0K | $-272.0K | $-2M | |
| Stock Issued | $0 | $43M | $-211.0K | $0 | $22M | $0 | $3M | $6M | $4M | $3M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $43M | · | · | · | $0 | · | · | · | $3M | · | · | · | · | · | · | |
| Financing Cash Flow | $-54.0K | $42M | $277.0K | $82.0K | $21M | $10M | $3M | $6M | $26M | $3M | $43.0K | $62M | $13M | $8M | $6M | $7M | |
| Net Change in Cash | $-10M | $36M | $-2M | $-4M | $13M | $4M | $-3M | $-5M | $13M | $-8M | $-10M | $12M | $-5M | $-3M | $-3M | $-18M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $15.0K | $1.0K | $14.0K | $0 | $4.0K | $0 | · | · | · | · | $-47.0K | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-5M | · | · | · | $-11M | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.8% | 86.2% | · | 83.5% | 83.9% | 83.7% | · | 86.3% | 87.6% | 85.0% | · | 88.7% | · | · | · | · | |
| Operating Margin | -86.0% | -94.5% | · | -77.9% | -65.4% | -80.0% | · | -118.9% | -111.0% | -181.0% | · | -355.8% | · | · | · | · | |
| Net Margin | -80.5% | 17.3% | · | -93.5% | -73.9% | -113.2% | · | -32.6% | -58.8% | -204.7% | · | -24.8% | · | · | · | · | |
| Pretax Margin | -80.5% | 17.3% | · | -93.4% | -73.9% | -113.1% | · | -32.7% | -58.7% | -204.7% | · | -24.8% | · | · | · | · | |
| EBITDA Margin | -86.0% | -94.5% | · | -77.9% | -65.4% | -80.0% | · | -118.9% | -111.0% | -181.0% | · | -355.8% | · | · | · | · | |
| ROA | -17.7% | 3.1% | · | -33.8% | -22.5% | -44.6% | · | -7.9% | -19.4% | -68.8% | · | -0.90% | -0.76% | -0.33% | · | 0.26% | |
| ROE | 142.7% | -14.3% | · | 45.9% | 38.0% | 29.9% | · | 40.2% | 22.1% | 54.2% | · | 81.1% | 7.5% | 3.2% | · | -4.2% | |
| ROIC | -24.8% | -18.3% | · | -149.3% | -57.0% | 274.5% | · | -701.6% | 286.0% | 33.5% | · | -217.7% | 11.0% | 6.5% | · | 2.9% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.8 | · | 3.1 | 4.1 | 2.1 | · | 2.4 | 2.3 | 0.9 | · | 3.1 | 0.0 | 0.1 | · | 0.2 | |
| Quick Ratio | 4.7 | 5.2 | · | 2.5 | 3.4 | 1.6 | · | 1.6 | 1.8 | 0.6 | · | 2.6 | 0.0 | 0.0 | · | 0.1 | |
| Debt / Equity | 5.0 | 2.6 | · | -1.2 | -1.7 | -0.9 | · | -1.1 | -0.9 | · | · | · | -0.1 | · | · | · | |
| LT Debt / Equity | 5.0 | 2.6 | · | -1.2 | -1.7 | -0.9 | · | -1.1 | -0.9 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -9.3 | -3895.0 | · | -4619.2 | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.4 | 0.3 | 0.4 | · | 0.2 | 0.3 | 0.3 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.7 | · | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.9 | 1.7 | · | 2.3 | 2.2 | 1.9 | · | 1.8 | 3.1 | 3.0 | · | 3.4 | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $41M | · | $39M | $35M | $30M | · | $26M | $24M | $19M | · | $17M | · | · | · | · | |
| Net Income TTM | $-27M | $-28M | · | $-32M | $-25M | $-30M | · | $-21M | $-33M | $-37M | · | $-32M | $-39M | $-33M | · | $-23M | |
| Market Cap | $49M | $74M | · | $85M | $49M | $39M | · | $31M | $44M | $27M | · | $10M | · | · | · | · | |
| Enterprise Value | $36M | $50M | · | $95M | $55M | $58M | · | $41M | $49M | · | · | · | · | · | · | · | |
| P/E | -0.6 | -0.8 | · | -1.0 | -1.3 | -0.9 | · | -0.9 | -0.0 | -0.0 | · | -0.0 | · | · | · | · | |
| P/S | 1.1 | 1.8 | · | 2.2 | 1.4 | 1.3 | · | 1.2 | 1.9 | 1.4 | · | 0.6 | · | · | · | · | |
| P/B | 7.5 | 5.8 | · | -3.2 | -2.5 | -1.1 | · | -1.5 | -1.8 | -0.8 | · | 1.2 | · | · | · | · | |
| P / Tangible Book | 7.5 | 5.8 | · | · | · | · | · | · | · | · | · | 1.3 | · | · | · | · | |
| P / Cash Flow | · | -11.4 | · | · | · | -8.7 | · | · | · | -2.5 | · | · | · | · | · | · | |
| P / FCF | · | -11.1 | · | · | · | -7.4 | · | · | · | -2.4 | · | · | · | · | · | · | |
| EV / EBITDA | -3.7 | -6.0 | · | -10.5 | -7.5 | -7.9 | · | -4.7 | -6.0 | · | · | · | · | · | · | · | |
| EV / FCF | · | -7.6 | · | · | · | -11.0 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.8 | 1.2 | · | 2.4 | 1.6 | 1.9 | · | 1.6 | 2.1 | · | · | · | · | · | · | · | |
| Earnings Yield | -170.0% | -132.5% | · | -102.4% | -76.7% | -109.1% | · | -105.9% | -2257.1% | -3715.0% | · | -16447.4% | · | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $45M | $29M | $19M | $12M | — |
| Marża Brutto % | 84.6% | 86.1% | 85.9% | — | — |
| Marża Operacyjna % | -59.7% | -122.9% | -292.5% | — | — |
| Zysk netto | $-39M | $-30M | $-59M | $-47M | $5M |
| Rozwodniony EPS | $-1.84 | $-1.31 | $-6.77 | $-161.55 | — |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | -1.0 | -0.9 | — | — | — |
| Wskaźnik bieżący | 2.8 | 2.0 | 1.4 | 0.1 | — |
| Wskaźnik Szybkości | 2.3 | 1.3 | 1.0 | 0.1 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-19M | $-41M | $-51M | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 6 emitentów · $1.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 0 (-1 vs poprzedni kw.) | 2 (0 vs poprzedni kw.) | 1 (0 vs poprzedni kw.) | 0 (-2 vs poprzedni kw.) | -19K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| JNB Advisors LLC | $1 075 867 | 827 590 | 59,12% | Akcje |
| Cerity Partners LLC | $662 072 | 827 590 | 36,38% | Akcje |
| ARISTEIA CAPITAL, L.L.C. | $56 872 | 74 826 | 3,13% | Akcje |
| Fort Baker Capital Management LP | $21 100 | 26 374 | 1,16% | Akcje |
| TORONTO DOMINION BANK | $3 929 | 5 170 | 0,22% | Akcje |
| Vestcor Inc | $54 | 70 832 | 0,00% | Akcje |
Insiderzy spółki 4 insiderów · 4 dyrektorzy generalni · 1 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mary T Szela | CEO and President | 30 czerwca 2026 A | 1 077 683 | 0 | 0 | $0 |
| David Patience | Chief Financial Officer | 1 lipca 2026 F | 261 107 | 0 | 0 | $0 |
| Richard Marshak | Chief Commercial Officer | 30 czerwca 2026 A | 128 319 | 0 | 0 | $0 |
| Richard Henry Marshall | Chief Medical Officer | 29 czerwca 2026 A | 90 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S